Ortho's $19.5M Deal Ending Antitrust MDL Gets Initial OK
By Dorothy Atkins (July 13, 2018, 4:58 PM EDT) -- A Pennsylvania federal judge on Thursday greenlighted Ortho-Clinical Diagnostics Inc.'s $19.5 million deal to resolve allegations in multidistrict litigation that the former Johnson & Johnson unit conspired with another company to fix prices on the reagents used in blood tests.
In the order, U.S. District Judge Jan E. DuBois preliminarily approved the settlement, finding that it's "sufficiently fair, reasonable and adequate." According to settlement papers, Ortho-Clinical's $19.5 million will be combined with a $22 million settlement that Immucor Inc. agreed to pay to resolve allegations against it, bringing the total settlement fund to $41.5 million.
Under the proposed settlement, class members...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!